ORGANOIDSCIENCES

Organoidsciences Ltd. is a South Korean company that develops regenerative therapies. Its pipeline includes ATORM, an adult tissue-derived organoid platform for treating intractable intestinal ulcers and diseases of the salivary glands, liver, and uterus; ODISEI, an organoid-based discovery platform for screening, evaluation, and identification; and EXPANSION, an organoid-based advanced science program for innovative solutions. The company was founded in 2018 and is based in Seongnam-si, South Korea.